i agree it raises many questions.
<<As you have mentioned the drug companies are not necessarily interested in supporting such a niche.
On the other hand, a side benefit of the effort to create a classifier also renders other information. Information that can, if discovered early in the development process, actually influence the eventual drug. Perhaps making it more 'universal' in scope or conversely, more finely targeted to a specific trait or population group. While this is a beneficial outcome to the patients and the industry, it does not necessarily have a viable business application. It is obvious that while such a service would be beneficial to a drug manufacturer, if there is no associated classifier there will be no revenue stream for DNAP.>>
frog, i think this is the crux of what tony is inferring about the classifiers not being where the big money maker is; but his goal is to use his knowledge of this to develop his own drugs with classifiers, and not simply to help big pharma either to make more money or find out how to keep the status quo.
i don't have any real idea or knowledge how the collaboration with moffit will pan out, or where the money making opportunities from it will be for dnap. perhaps in the long run just the knowledge and insight they gain for their use in developing their own drugs from all the research being done. with my limited knowledge in this field i have to be content on my basic belief of what tony is trying to do, and wait for him to succeed or fail. there is so much speculation here about what is happening and what dnap should be doing which is interesting; but, i'm basically waiting for pr's from the co to let me know what progress is being made. as i stated in a previous post, i went to the mtg, to see and hear in person the people involved; what they had to say and their tone and demeanor. in that regard i was satified. i tried to relate some things that were said, but don't want to pretend that i have some deep knowledge of the science and what they are trying to do. hope this helps.